YC W22
WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
About
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
Founders
- Julien Cottineau
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in WhiteLab Genomics.
See family office activityIndustry & Focus
HealthcareDrug Discovery and DeliveryArtificial IntelligenceGene TherapyCell TherapyGenomics